Opthea Valuation
| OPTDelisted Stock | USD 3.41 0.07 2.01% |
At this time, the company appears to be fairly valued. Opthea holds a recent Real Value of $3.36 per share. The prevailing price of the company is $3.41. Our model determines the value of Opthea from analyzing the company fundamentals such as Return On Equity of -33.83, current valuation of 492.14 M, and Shares Owned By Institutions of 3.68 % as well as examining its technical indicators and probability of bankruptcy.
Fairly Valued
Today
Please note that Opthea's price fluctuation is very steady at this time. Calculation of the real value of Opthea is based on 3 months time horizon. Increasing Opthea's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Opthea's intrinsic value may or may not be the same as its current market price of 3.41, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 3.41 | Real 3.36 | Hype 3.41 | Naive 3.73 |
The intrinsic value of Opthea's stock can be calculated using various methods such as discounted cash flow analysis, price-to-earnings ratio, or price-to-book ratio. That value may differ from its current market price, which is determined by supply and demand factors such as investor sentiment, market trends, news, and other external factors that may influence Opthea's stock price. It is important to note that the real value of any stock may change over time based on changes in the company's performance.
Estimating the potential upside or downside of Opthea helps investors to forecast how Opthea stock's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of Opthea more accurately as focusing exclusively on Opthea's fundamentals will not take into account other important factors: Opthea Total Value Analysis
Opthea is now projected to have company total value of 492.14 M with market capitalization of 524.82 M, debt of 141.65 M, and cash on hands of 44.63 M. Please note that company total value may be misleading and is a subject to accounting gimmicks. We encourage investors to carefully check all of the Opthea fundamentals before making security assessment based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
492.14 M | 524.82 M | 141.65 M | 44.63 M |
Opthea Investor Information
The company recorded a loss per share of 2.25. Opthea had not issued any dividends in recent years. The entity had 5:8 split on the 15th of October 2020. Based on the key measurements obtained from Opthea's financial statements, Opthea is not in a good financial situation at the moment. It has a very high risk of going through financial straits in February.Opthea Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. Opthea has an asset utilization ratio of 0.066 percent. This implies that the Company is making $6.6E-4 for each dollar of assets. An increasing asset utilization means that Opthea is more efficient with each dollar of assets it utilizes for everyday operations.Opthea Ownership Allocation
Opthea owns a total of 153.91 Million outstanding shares. Roughly 96.32 pct. of Opthea outstanding shares are held by general public with 3.68 (%) by third-party entities. Please note that no matter how many assets the company maintains, if the real value of the company is less than the current market value, you may not be able to make money on it.Opthea Profitability Analysis
The company reported the last year's revenue of 124.67 K. Reported Net Loss for the year was (220.24 M) with profit before taxes, overhead, and interest of 208.86 K.About Opthea Valuation
The delisted stock valuation mechanism determines Opthea's current worth on a daily basis. In general, an absolute valuation approach attempts to find the value of Opthea based exclusively on its fundamental and basic technical indicators. As compared to an absolute model, our relative valuation model uses a comparative analysis of Opthea. We calculate exposure to Opthea's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of Opthea's related companies.Opthea Limited, a clinical stage biopharmaceutical company, develops and commercializes therapies primarily for eye disease in Australia. Opthea Limited was incorporated in 1984 and is based in South Yarra, Australia. Opthea operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange.
Opthea Growth Indicators
Investing in growth stocks can be very risky. If the company such as Opthea does not do well, investors take a loss on the stock when it is time to sell. Also, because growth stocks typically do not pay dividends, the only opportunity an investor has to make money on their investment is when they eventually sell their shares.
| Common Stock Shares Outstanding | 79.8 M | |
| Forward Price Earnings | 6.734 |
Check out Your Equity Center to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in inflation. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Opthea Stock
If you are still planning to invest in Opthea check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Opthea's history and understand the potential risks before investing.
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments | |
| Global Markets Map Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals | |
| Portfolio Suggestion Get suggestions outside of your existing asset allocation including your own model portfolios | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation |